If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
217.20    -8.80 (-3.89%)
Bid:
217.00
Ask:
217.40
Spread: 0.40 (0.184%)
Market Cap: £950.77m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Director/PDMR Shareholding

8 Nov 2024 10:36

RNS Number : 5510L
Kier Group PLC
08 November 2024
 

8 November 2024

 

KIER GROUP PLC

 

DIRECTOR / PDMR SHAREHOLDING

 

Kier Group plc (the "Company") announces that, on 6 November 2024, Mr Leigh Thomas, a Person Discharging Managerial Responsibilities ('PDMR') of the Company, and Ms Megan Thomas, a person closely associated ('PCA') with Mr Leigh Thomas, undertook the transactions in the ordinary shares of 1p each in the capital of the Company ('Shares') shown in the table below:

 

PDMR/PCA

Date

Transaction/Number of Shares

 

Price per Share

£

Mr L Thomas (PDMR)

6 November 2024

Sale of 7,199 Shares

1.390841

Ms M Thomas (PCA)

6 November 2024

Purchase of 7,131 Shares

1.393555

 

 

The following notifications are made in accordance with the requirements of Article 19(3) of the UK Market Abuse Regulation. The Company's Legal Entity Identifier ("LEI") is 2138002RKCU2OM4Y7O48.

 

For enquiries please contact:

Jaime Tham

Company Secretary

07801 975672

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Leigh Thomas, PDMR

2

Reason for the notification

a)

Position / status

Group Managing Director - Property

b)

Initial notification / Amendment

Initial notification

3

Details of issuer

a)

Name

Kier Group plc

b)

LEI

2138002RKCU2OM4Y7O48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p each in Kier Group plc

 

 

GB0004915632

b)

Nature of the transaction

 

Sale of 7,199 ordinary shares of 1p each

 

Price(s) and volume(s)

 

 

Price

Volume

£1.390841 per share

7,199 shares

d)

Aggregated information

Aggregated volume

Price

 

7,199 ordinary shares

£10,012.66

 

e)

Date of the transaction

 

2024-11-06

 

f)

Place of the transaction

 

London Stock Exchange, Main Market (XLON)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Megan Thomas, PCA

 

2

Reason for the notification

a)

Position / status

PCA to PDMR

b)

Initial notification / Amendment

Initial notification

3

Details of issuer

a)

Name

Kier Group plc

b)

LEI

2138002RKCU2OM4Y7O48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p each in Kier Group plc

 

 

GB0004915632

b)

Nature of the transaction

 

Purchase of 7,131 ordinary shares of 1p each

 

 

Price(s) and volume(s)

 

 

Price

Volume

£1.393555 per share

7,131 shares

d)

Aggregated information

Aggregated volume

Price

 

7,131 ordinary shares

 £9,937.44

e)

Date of the transaction

 

2024-11-06

 

f)

Place of the transaction

 

London Stock Exchange, Main Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBPBMTMTJMBBI
Date   Source Headline
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:45 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:33 amRNSTransaction in Own Shares
21st Jan 20252:11 pmRNSDirector/PDMR Shareholding
21st Jan 20257:01 amRNSLaunch of £20m share buyback programme
21st Jan 20257:00 amRNSTrading Update
2nd Jan 202511:05 amRNSBlock listing Interim Review
20th Dec 202411:20 amRNSDirector/PDMR Shareholding
13th Dec 20241:11 pmRNSDirector/PDMR Shareholding
10th Dec 20243:34 pmRNSDirector/PDMR Shareholding
6th Dec 202410:37 amRNSHolding(s) in Company
5th Dec 20249:14 amRNSNotification of Change of Director Details
4th Dec 20244:43 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:39 pmRNSTotal Voting Rights
20th Nov 20244:03 pmRNSDirector/PDMR Shareholding
18th Nov 202411:47 amRNSHolding(s) in Company
14th Nov 20242:45 pmRNSResult of AGM
14th Nov 20247:00 amRNSAGM Trading Update
13th Nov 20242:58 pmRNSHolding(s) in Company
8th Nov 202410:36 amRNSDirector/PDMR Shareholding
4th Nov 20245:28 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20243:21 pmRNSDirector/PDMR Shareholding
29th Oct 202411:26 amRNSBlock Listing Application
22nd Oct 202412:47 pmRNSDirector/PDMR Shareholding
16th Oct 20244:23 pmRNSAnnual Financial Report Amendment
14th Oct 20242:53 pmRNSDirector/PDMR Shareholding
4th Oct 202412:00 pmRNSAnnual Financial Report
1st Oct 202412:09 pmRNSTotal Voting Rights
23rd Sep 20242:03 pmRNSHolding(s) in Company
23rd Sep 202410:21 amRNSDirector/PDMR Shareholding
12th Sep 20247:05 amRNSDirectorate Change
12th Sep 20247:00 amRNSFY24 Results
6th Sep 20242:29 pmRNSHolding(s) in Company
2nd Sep 202412:33 pmRNSTotal Voting Rights
22nd Aug 20241:51 pmRNSDirector/PDMR Shareholding
12th Aug 20245:32 pmRNSNotice of Results and Presentations
1st Aug 20249:59 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSFull Year 2024 Trading Update
16th Jul 20243:38 pmRNSHolding(s) in Company
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:28 amRNSTotal Voting Rights
28th Jun 20244:34 pmRNSDirector/PDMR Shareholding
27th Jun 20244:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.